Article
Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features?
Archives of pathology & laboratory medicine - 1 Jan 2010
Inamura Kentaro, Ninomiya Hironori, Ishikawa Yuichi, Matsubara Osamu
Abstract excerpt
CONTEXT: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors are molecular-targeted drugs that are innovatively effective for non-small cell lung carcinomas with EGFR mutations. Epidermal growth factor receptor is a transmembrane receptor forming dimers on ligand binding. These then stimulate signals by activating receptor autophosphorylation through tyrosine kinase activity. Autophosphorylation...
Topics
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Enzyme Inhibitors
- ErbB Receptors
- Humans
- Lung Neoplasms
- Mutation
- Protein-Tyrosine Kinases
